Cargando…
Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies
Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease with a wide range of clinical expressions. The kidney is often affected, usually within 5 years of the onset of SLE, and lupus nephropathy (LN) carries a high risk for increased morbidity. The clinical heterogeneity of the...
Autores principales: | Infante, Barbara, Mercuri, Silvia, Dello Strologo, Andrea, Franzin, Rossana, Catalano, Valeria, Troise, Dario, Cataldo, Emanuela, Pontrelli, Paola, Alfieri, Carlo, Binda, Valentina, Frontini, Giulia, Netti, Giuseppe Stefano, Ranieri, Elena, Gesualdo, Loreto, Castellano, Giuseppe, Stallone, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783870/ https://www.ncbi.nlm.nih.gov/pubmed/36555640 http://dx.doi.org/10.3390/ijms232415998 |
Ejemplares similares
-
Role of Complement in Regulating Inflammation Processes in Renal and Prostate Cancers
por: Netti, Giuseppe Stefano, et al.
Publicado: (2021) -
Hypoxic State of Cells and Immunosenescence: A Focus on the Role of the HIF Signaling Pathway
por: Troise, Dario, et al.
Publicado: (2023) -
Recent advances in molecular mechanisms of acute kidney injury in patients with diabetes mellitus
por: Infante, Barbara, et al.
Publicado: (2023) -
mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients
por: Netti, Giuseppe S., et al.
Publicado: (2022) -
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
por: Franzin, Rossana, et al.
Publicado: (2020)